About the Authors
- Alyson M. Auliff
-
Affiliations Drug Resistance and Diagnostics Department, Australian Army Malaria Institute, Enoggera, Queensland, Australia, School of Population Health, University of Queensland, Brisbane, Queensland, Australia
- Bharath Balu
-
Current address: Tropical Disease Research Program, Center for Infectious Disease and Biodefense Research, SRI International, Harrisonburg, Virginia, United States of America
Affiliation Department of Global Health, University of South Florida, Tampa, Florida, United States of America
- Nanhua Chen
-
Affiliation Drug Resistance and Diagnostics Department, Australian Army Malaria Institute, Enoggera, Queensland, Australia
- Michael T. O’Neil
-
Affiliation Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
- Qin Cheng
-
* E-mail: jadams3@health.usf.edu (JHA); qin.cheng@defence.gov.au (QC)
Affiliations Drug Resistance and Diagnostics Department, Australian Army Malaria Institute, Enoggera, Queensland, Australia, School of Population Health, University of Queensland, Brisbane, Queensland, Australia
- John H. Adams
-
* E-mail: jadams3@health.usf.edu (JHA); qin.cheng@defence.gov.au (QC)
Affiliation Department of Global Health, University of South Florida, Tampa, Florida, United States of America
Competing Interests
While Jacobus Pharmaceutical Company (Princeton, New Jersey) kindly supplied the antimalarial compounds WR99210 and JPC-2067 and Dr. Don Gardiner, QIMR (Brisbane, Australia) kindly supplied Rex 1 antibody, the authors do not have commercial or other association that might pose a conflict. This does not alter the authors’ adherance to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: AMA QC JHA. Performed the experiments: AMA BB. Analyzed the data: AMA BB MTO NC QC. Contributed reagents/materials/analysis tools: QC JHC. Wrote the paper: AMA.